FARE Chief Medical Advisor Publishes New Guidance to Treat Patients Experiencing Anaphylaxis Amid COVID-19 Spread: New Recommendations Come as Patients Suffering Severe Allergic Reactions Fear Visiting Emergency Departments
The provider team at Grand Rapids Allergy has reviewed these published recommendations and is in agreement about a modified approach to food allergy anaphylaxis during COVID-19 spread. If you wish to review these recommendations and/or ask questions of a provider, please call to schedule a telemedicine visit.
Read the FARE Press release here.
Below is the algorithm graphic.
FARE (Food Allergy Research & Education) is the world’s leading food allergy advocacy organization and the largest private funder of food allergy research. Our mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. FARE is transforming the future of food allergy through innovative initiatives that will lead to increased awareness, new and improved treatments and prevention strategies, effective policies and legislation and novel approaches to managing the disease. www.foodallergy.org. To join FARE’s transformative five-year fundraising and awareness campaign, Contains: Courage®, supporting families living with food allergies and educating ALL communities about the disease, visit www.foodallergy.org/containscourage.